Information Library

Results for: Clinical Services - Our Expertise - Late Phase

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Understanding the Complexity of HTA Networks

    Presentation — November 27, 2011
    As stakeholders’ influence shifts, demonstrating value is imperative for the success of every pharmaceutical product. Learn more about Quintiles HTA Watch service.

  • Quintiles Strengthens Late Phase Offerings with Acquisition of Outcome Sciences, Inc.

    Press Release — October 19, 2011 – With late phase (Phase IIIB and Phase IV) research becoming increasingly important to multiple healthcare stakeholders, Quintiles has acquired Outcome Sciences, Inc. (Outcome).

  • Quintiles Names New Global Head of Clinical & Data Operations

    Press Release — October 6, 2011 – Quintiles announced that Steven Skolsky has been appointed Global Head of its Clinical & Data Operations (CDO) unit.

  • Methods Matter

    White Paper — July 18, 2011
    As healthcare decision making becomes more complex, stakeholders are demanding real-world evidence tailored to their own individual needs.

  • A Focus on CNS

    Brochure — July 1, 2011
    Quintiles is your ally for broad and deep CNS expertise in every aspect of the drug development process.

  • PharmAsia News Article Reprint

    Media Coverage — March 1, 2010
    Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News.

Page 1 of 1 (6 results)

Subscribe to Email Based on Your Interests

Set preferences